Juvena Therapeutics

Biotechnology · Cell & Gene Therapy

Facts

as of Nov 20, 2026

Juvena Therapeutics is a clinical-stage biotechnology company engineering proteins that human stem cells naturally secrete into regenerative medicines. We.

Legal name
Juvena Therapeutics, Inc.
Headquarters
San Mateo, United States
Founded
2017
Employees
28US Form 5500 (plan participants) · Dec 2025 · +17% in a year
Register numbers
EIN 823071414
Official records
SEC CIK 1732720

These are the key facts about Juvena Therapeutics on Alion as of Nov 20, 2026. Juvena Therapeutics is headquartered in San Mateo, United States. It was founded in 2017. It has raised $34.8M in 2 funding rounds. The latest round is Series B of $30.5M, announced in 2025.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Legal entity active
Juvena Therapeutics, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 2 cities in 1 country.

2Cities
1Countries
Loading the map
SiteTypeOpen rolesHires most forEngineering
San Mateo United StatesHeadquarters0
Redwood City United StatesHeadquarters0
Source: office addresses in postings and company registers

Financials

Funding rounds, investors and revenue on record.

$34.8MTotal raised
$254kPublic grants1 public grant
Series BLatest round
3Rounds and grants
Money by yearUSD, rounds and grants
2025$30.5M1 record
2021$254k1 record
2018$4.3M1 record
Largest rounds and grants
$30.5M
2021
$254k
Sources: funding announcements, grant and company registers

Money

Juvena Therapeutics has $34.8M paid in by investors, lenders and donors.

$34.8MPaid in
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
Equity raised
Jun 2025 · Series B
$30.5MPaid
Grant
Sep 2021 · Grant
$254kPaid
Equity raised
Feb 2018 · Venture round
$4.3MPaid
Taxes
No public tax figures for this company or its entities.
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".

Public record

Juvena Therapeutics in public registers.

Patents
Published US applications
6
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.

Milestones

2025
Team of 28 was 24 · US Form 5500 (plan participants)
Jun 27, 2025
Sep 1, 2021
Won a grant $254k · CORDIS
2017
Founded
Each milestone is dated by its source: registers, filings, the press